Gimv, a European investment titan with over 40 years’ experience in private equity, has successfully raised €247,000,000 in its latest funding round—a significant milestone that underscores its reputation as a market leader in the investment arena. With a robust portfolio consisting of around 60 portfolio companies that collectively generate a turnover of €3.7 billion and employ more than 20,000 individuals, Gimv is well-positioned to continue its tradition of identifying and nurturing high-growth, entrepreneurial ventures. Listed on Euronext Brussels and managing assets worth approximately €1.5 billion, the company’s latest capital raise demonstrates strong investor confidence in its strategic vision and operational expertise across its five dedicated investment platforms: Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities.
This fresh capital injection is earmarked to further empower Gimv’s mission of transforming ambitious companies into market leaders. By harnessing patient capital and a flexible investment approach, Gimv plans to accelerate growth and innovation for select ventures, fueling expansion and driving long-term value creation. The strategic infusion of funds will be used to develop cutting-edge solutions across its diversified sectors and expand its international network of experts. As a trusted partner for companies looking to scale, Gimv remains committed to guiding entrepreneurial ventures through transformative growth phases, helping them navigate challenges and seize new opportunities. For details on our investment strategies and ongoing projects, visit www.gimv.com. This funding round is not only a validation of Gimv’s past successes but also a forward-looking commitment to fostering sustainable growth and creating tomorrow’s industry leaders.
